Lincocin forte s intramammary solution
Country: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Vara einkenni
(SPC)
27-05-2024
Sum skjöl fyrir þessa vöru eru ekki tiltæk eins og er, þú getur sent beiðni til þjónustu við viðskiptavini okkar og við munum láta þig vita um leið og við getum fengið þau.
Senda beiðni.
Senda beiðni.
Virkt innihaldsefni:
lincomycin hydrochloride neomycin sulfate
Fáanlegur frá:
Zoetis Ireland Limited
ATC númer:
QJ51RF03
Skammtar:
330/100 mg/syringe
Lyfjaform:
intramammary Solution
Meðferðarhópur:
Bovine
Lækningarsvæði:
Antibacterial
Leyfisstaða:
Authorised
Vara einkenni
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Lincocin Forte S Intramammary Solution
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary Solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Lactating cow.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of mastitis in lactating cattle. The product is effective against Staphylococcus species (both penicillinase
and non-penicillinase producers) including _Staphylococcus aureus, _Streptococcus species including _Streptococcus_
_agalactiae, Streptococcus dysgalactiae _and _Streptococcus uberis, _and coliform bacteria including _Escherichia coli_.
4.3 CONTRAINDICATIONS
None.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each 10 ml syringe contains:
Active substances
Lincomycin
(as Lincomycin Hydrochloride) 330 mg
Neomycin
(as Neomycin Sulphate)
100 mg
HEALTH PRODUCTS REGULATORY AUTHORITY
________________________________________________________________________________________________________________________
_Date Printed 18/07/2014_
_CRN 7018025_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible,
therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target
bacteria.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS
Avoid contact with the solution. Wash hands and any exposed skin immediately.
4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
None known.
4.7 USE DURING PREGNANCY, LACTATION OR LAY
No restrictions.
4.8 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERA
Lestu allt skjalið
